Model
Edge
Protalix Biotherapeutics Inc.
0001625184
Filing Type
4
Filing Date
9/8/2022
Updated
9/9/22, 11:02 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership